News Report clears researcher who broke drug company agreement BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7321.1085 (Published 10 November 2001) Cite this as: BMJ 2001;323:1085 Article Related content Metrics Responses Peer review Related articles Letter News article on report about drug researcher was biased Published: 09 March 2002; BMJ 324 doi:10.1136/bmj.324.7337.612/a Feature Whistleblower’s decades long fight to save patients from dangerous research Published: 06 March 2024; BMJ 384 doi:10.1136/bmj.q526 See more Trump chooses Obamacare opponent to lead Health and Human Services BMJ November 30, 2016, 355 i6469; DOI: https://doi.org/10.1136/bmj.i6469 Drug firms need to tackle affordability BMJ November 14, 2016, 355 i6096; DOI: https://doi.org/10.1136/bmj.i6096 World Medical Association’s tainted president, Ketan Desai BMJ November 10, 2016, 355 i5867; DOI: https://doi.org/10.1136/bmj.i5867 Cancer drugs, survival, and ethics BMJ November 09, 2016, 355 i5792; DOI: https://doi.org/10.1136/bmj.i5792 WHO refers $29m Oxford research project to GMC for misconduct BMJ November 07, 2016, 355 i5971; DOI: https://doi.org/10.1136/bmj.i5971 Cited by... Whistleblowers decades long fight to save patients from dangerous researchFulltext PDF The Olivieri debacle: where were the heroes of bioethics?Fulltext PDF Abstract Whistleblower vows to fight onFulltext PDF Abstract How to dance with porcupines: rules and guidelines on doctors' relations with drug companiesFulltext PDF Abstract News article on report about drug researcher was biasedFulltext PDF Abstract